Tricyclic heteroaryl compounds useful as IRAK4 inhibitors
US-12286428-B2 · Apr 29, 2025 · US
US12552985B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12552985-B2 |
| Application number | US-202017781291-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 27, 2020 |
| Priority date | Dec 2, 2019 |
| Publication date | Feb 17, 2026 |
| Grant date | Feb 17, 2026 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present specification relates to a heterocyclic compound represented by Chemical Formula 1, and an organic light emitting device including the same.
Opening claim text (preview).
The invention claimed is: 1 . A heterocyclic compound represented by the following Chemical Formula 1: wherein, in Chemical Formula 1, R1 to R5 are each independently hydrogen; deuterium; a halogen group; a cyano group; a substituted or unsubstituted alkyl group having 1 to 60 carbon atoms; a substituted or unsubstituted aryl group having 6 to 60 carbon atoms; or a substituted or unsubstituted heteroaryl group having 2 to 60 carbon atoms; L is a direct bond; a substituted or unsubstituted arylene group having 6 to 60 carbon atoms; or a substituted or unsubstituted heteroarylene group having 2 to 60 carbon atoms; and Z is a substituted or unsubstituted aryl group having 10 to 60 carbon atoms; or a substituted or unsubstituted phosphine oxide group, or represented by the following Chemical Formula 2; in Chemical Formula 2, X1 to X3 are each CR or N, and at least one thereof is N; R, R21 and R22 are each independently hydrogen; deuterium; a substituted or unsubstituted alkyl group having 1 to 60 carbon atoms; a substituted or unsubstituted aryl group having 6 to 60 carbon atoms; or a substituted or unsubstituted heteroaryl group having 2 to 60 carbon atoms; adjacent groups among X1 to X3, R21 and R22 may bond to each other to form a substituted or unsubstituted ring; r is an integer of 0 to 3; a and b are each an integer of 1 to 5; and when r, a and b are each 2 or greater, substituents in the parentheses are the same as or different from each other. 2 . The heterocyclic compound of claim 1 , wherein Chemical Formula 1 is represented by any one of the following Chemical Formulae 1-1 to 1-4: in Chemical Formulae 1-1 to 1-4, each substituent has the same definition as in Chemical Formula 1. 3 . The heterocyclic compound of claim 1 , wherein Z is a substituted or unsubstituted anthracenyl group; or a phosphine oxide group unsubstituted or substituted with an alkyl group, or represented by Chemical Formula 2. 4 . The heterocyclic compound of claim 1 , wherein Chemical Formula 2 is any one selected from among the following structural formulae: in the structural formulae, R31 and R32 are each independently a substituted or unsubstituted alkyl group having 1 to 20 carbon atoms; a substituted or unsubstituted aryl group having 6 to 60 carbon atoms; or a substituted or unsubstituted heteroaryl group having 2 to 60 carbon atoms, and R33 is hydrogen; deuterium; or a substituted or unsubstituted aryl group having 6 to 60 carbon atoms. 5 . The heterocyclic compound of claim 1 , wherein at least two of R1 to R3 are each independently a cyano group; a substituted or unsubstituted alkyl group having 1 to 10 carbon atoms; or a substituted or unsubstituted aryl group having 6 to 20 carbon atoms. 6 . The heterocyclic compound of claim 1 , wherein Chemical Formula 1 is represented by any one of the following compounds:
Tandem OLEDs · CPC title
Carrier blocking layers · CPC title
Electron transporting layers · CPC title
comprising only nitrogen as heteroatom (H10K85/652 takes precedence) · CPC title
comprising only nitrogen in the heteroaromatic polycondensed ring system, e.g. phenanthroline or carbazole · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.